Granite Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-76,970
Closed -$5.8M 166
2018
Q1
$5.8M Buy
76,970
+1,577
+2% +$125K 1.06% 35
2017
Q4
$5.4M Sell
75,393
-16,003
-18% -$1.22M 0.95% 35
2017
Q3
$7.41M Buy
91,396
+165
+0.2% +$12.6K 1.34% 27
2017
Q2
$6.73M Sell
91,231
-1,950
-2% -$130K 1.22% 31
2017
Q1
$6.33M Buy
93,181
+14,151
+18% +$995K 1.13% 35
2016
Q4
$5.66M Sell
79,030
-13,776
-15% -$1.02M 1.16% 42
2016
Q3
$7.34M Buy
92,806
+30,215
+48% +$2.45M 1.51% 22
2016
Q2
$5.22M Sell
62,591
-770
-1% -$68.3K 1.06% 46
2016
Q1
$5.82M Sell
63,361
-937
-1% -$84.5K 1.18% 38
2015
Q4
$6.51M Sell
64,298
-3,277
-5% -$341K 1.33% 29
2015
Q3
$6.63M Sell
67,575
-3,265
-5% -$363K 1.29% 35
2015
Q2
$8.29M Buy
+70,840
New +$7.74M 1.45% 28

Other funds holding GILD

Granite Investment Advisors's GILD Position: Q2 2018 in Review

Granite Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 76,970 shares — an estimated $5.8M sold.

Granite Investment Advisors first reported a position in GILD in Q2 2015 and held it in 12 quarters. The position peaked at $8.29M in Q2 2015. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Granite Investment Advisors reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Granite Investment Advisors sold 76,970 Gilead Sciences shares in Q2 2018, an estimated $5.8M.
  • Granite Investment Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 12 quarters.
  • Granite Investment Advisors's Gilead Sciences position peaked at $8.29M in Q2 2015.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Granite Investment Advisors's 13F filing for Q2 2018, filed 26 Jul 2018.